首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2958篇
  免费   124篇
  国内免费   9篇
化学   2150篇
晶体学   3篇
力学   45篇
数学   427篇
物理学   466篇
  2023年   26篇
  2022年   23篇
  2021年   51篇
  2020年   59篇
  2019年   69篇
  2018年   37篇
  2017年   32篇
  2016年   91篇
  2015年   113篇
  2014年   107篇
  2013年   167篇
  2012年   230篇
  2011年   221篇
  2010年   128篇
  2009年   117篇
  2008年   150篇
  2007年   162篇
  2006年   176篇
  2005年   151篇
  2004年   173篇
  2003年   121篇
  2002年   96篇
  2001年   56篇
  2000年   32篇
  1999年   37篇
  1998年   41篇
  1997年   39篇
  1996年   25篇
  1995年   38篇
  1994年   38篇
  1993年   20篇
  1992年   25篇
  1991年   24篇
  1990年   12篇
  1989年   20篇
  1988年   10篇
  1987年   8篇
  1985年   7篇
  1984年   9篇
  1982年   11篇
  1981年   6篇
  1980年   6篇
  1979年   24篇
  1978年   13篇
  1977年   12篇
  1976年   8篇
  1974年   6篇
  1973年   12篇
  1970年   4篇
  1969年   4篇
排序方式: 共有3091条查询结果,搜索用时 15 毫秒
71.
72.
We report on the controlled free radical homopolymerization of 1‐ferrocenylethyl acrylate as well as of three new ferrocene bearing monomers, namely 4‐ferrocenylbutyl acrylate, 2‐ferrocenylamido‐2‐methylpropyl acrylate, and 4‐ferrocenylbutyl methacrylate, by the RAFT technique. For comparison, the latter monomer was polymerized using ATRP, too. The ferrocene containing monomers were found to be less reactive than their analogues free of ferrocene. The reasons for the low polymerizability are not entirely clear. As the addition of free ferrocene to the reaction mixture did not notably affect the polymerizations, sterical hindrance by the bulky ferrocene moiety fixed on the monomers seems to be the most probable explanation. Molar masses found for 1‐ferrocenylethyl acrylate did not exceed 10,000 g mol?1, while for 4‐ferrocenylbutyl (meth)acrylate molar masses of 15,000 g mol?1 could be obtained. With PDIs as low as 1.3 in RAFT polymerization of the monomers, good control over the polymerization was achieved. © 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2012  相似文献   
73.
74.
75.
76.
77.
78.
Abstract

The synthesis of a cyclic α-amino phosphine oxide and sulfide with an incorporated benzo-thiazine moiety is described. The products can be regarded as analogues of the biologically active thiazolidinylphosphonates, in which several characteristic functional groups have been modified.  相似文献   
79.
A cascade, composed of (i) oxovanadium(V)-catalyzed oxidation of bromide by tert-butyl hydroperoxide and (ii) stereoselective 6-endo-bromocyclization, affords 3-bromo-2-aryl-2,6,6-trimethyltetrahydropyrans from styrene-type tertiary alkenols in synthetically useful yields. (E)-Alkenols add the bromo- and the alkoxy substituent anti-selectively across the double bond, indicating a bromonium ion-mechanism for the ring closure. 6-endo-control of the alkenol cyclization thereby arises from the polar effect of the aryl substituent. Two methyl substituents bound to the alkene terminus are not similarly able to favor 6-endo-cyclization, because strain arising from methyl group repulsion, as the bromonium-activated π-bond and the hydroxyl oxygen approach, directs bromocyclization of tertiary prenyl-type substrates toward tetrahydrofuran formation. A hexasubstituted bromotetrahydropyran prepared from the oxidation/bromocyclization cascade served as starting material for synthesis of racemic aplysiapyranoid A, in a sequence of free radical and polar functional group interconversion.  相似文献   
80.
The screening files of many large companies, including Pfizer, have grown considerably due to internal chemistry efforts, company mergers and acquisitions, external contracted synthesis, or compound purchase schemes. In order to screen the targets of interest in a cost-effective fashion, we devised an easy-to-assemble, plate-based diversity subset (PBDS) that represents almost the entire computed chemical space of the screening file whilst comprising only a fraction of the plates in the collection. In order to create this file, we developed new design principles for the quality assessment of screening plates: the Rule of 40 (Ro40) and a plate selection process that insured excellent coverage of both library chemistry and legacy chemistry space. This paper describes the rationale, design, construction, and performance of the PBDS, that has evolved into the standard paradigm for singleton (one compound per well) high-throughput screening in Pfizer since its introduction in 2006.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号